tiprankstipranks
Can-Fite BioPharma (CANF)
:CANF
US Market

Can-Fite BioPharma (CANF) Income Statement

Compare
557 Followers

Can-Fite BioPharma Income Statement

Last quarter (Q2 2024), Can-Fite BioPharma's total revenue was $158.00K, a decrease of -19.39% from the same quarter last year. In Q2, Can-Fite BioPharma's net income was $-1.98M. See Can-Fite BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 743.00K$ 810.00K$ 853.00K$ 763.00K$ 2.03M
Gross Profit
$ 743.00K$ 810.00K$ 853.00K$ 763.00K$ 2.03M
Operating Expenses
$ 8.94M$ 10.91M$ 13.70M$ 14.90M$ 14.04M
Depreciation and Amortization
$ 15.00K$ 14.00K$ 14.00K$ 12.00K$ 14.00K
EBITDA
$ -8.18M$ -10.08M$ -12.83M$ -14.13M$ -11.99M
Operating Income
$ -8.20M$ -10.10M$ -12.84M$ -14.14M$ -12.01M
Other Income/Expenses
$ 561.00K$ -77.00K$ 227.00K$ -304.00K$ -618.00K
Pretax Income
$ -7.63M$ -10.17M$ -12.62M$ -14.44M$ -12.63M
Net Income
$ -7.63M$ -10.17M$ -12.62M$ -14.44M$ -12.63M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.79$ -0.01$ -0.03$ -0.04$ -0.15
Diluted EPS
$ -1.79$ -0.01$ -0.02$ -0.04$ -0.15
Weighted Average Shares Outstanding
4.26M 815.80M 458.88M 341.51M 85.91M
Weighted Average Shares Outstanding (Diluted)
4.26M 815.75M 553.08M 358.41M 85.91M
Currency in USD

Can-Fite BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis